ArticleExperimental dermatology2026
Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.
Laura Calabrese et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it